BALTIMORE – August 31, 2016 – Latham BioPharm Group (LBG), a premier provider of life science consulting services to customers in the federal and commercial sectors, today announced the expansion of company operations and the opening of new office space in Baltimore, MD. The new space is located within the heart of the Inner Harbor, in the Columbus Center at 701 E. Pratt Street, Baltimore, Maryland.
LBG has experienced significant success in supporting life science companies with strategic consulting services, and this expansion will allow for concentrated growth in one of LBG’s core markets. The company supports client contracts with multiple US Government offices, including agencies and institutes of both HHS and DoD. In addition, LBG supports commercial engagements with biopharmaceutical, diagnostic and medical device companies, as well as academic institutions and non-governmental organizations (NGOs). These clients span from virtual companies to global market leaders.
LBG President, Peter Latham, commented by saying; “We are thrilled about our new presence near our federal sector clients and the world class talent pool in the National Capital region. This is an exciting step in the ongoing growth of LBG and our ability to provide quality service to our clients.”
About Latham BioPharm Group
Latham BioPharm Group (LBG), headquartered in Maynard, Massachusetts, unites teams and technologies in the life sciences by providing high level business development, program management, technical, and strategic consulting services. The company is a leading provider of services to life science companies looking to secure, or who have secured, funding in both the federal and commercial sectors.
For more information, please contact at 978.266.9151.
